drugset / Trial / NCT00100269

Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility

NCT00100269 ↗

Phase 3 Completed 60 enrolled Repromed
RandomizedParallel-groupDouble-blindTreatment

Summary

Oxidative stress related damage to sperm is believed to be a major cause of male infertility. The object of the Menevit study is to investigate the role of a novel anti-oxidant preparation (Menevit) on sperm function, embryo quality and pregnancy rates in an in vitro fertilization (IVF) setting.

Timeline

Start
2004-12
Primary completion
—
Completion
2006-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Menevit Other / unclassified — Oral